View
213
Download
1
Embed Size (px)
DESCRIPTION
Virendra Goyal. Late presentation of secondary cycling - nitrobenzene poisoning: A rare case report. IAIM, 2014; 1(3): 39-43.
Citation preview
Late presentation of secondary cycling
International Archives of Integrated Medicine, Vol.
Copy right © 2014, IAIM, All Rights Reserved.
Case Report
Late presentation of secondary cycling
nitrobenzene poisoning: A rare case report
142,Taruchaya Nagar,
*Corresponding author’s email:
How to cite this article: Virendra Goyal. L
poisoning: A rare case report. IAIM, 2014; 1(3):
Available online at
Received on: 14-10-2014
Abstract
We presented here a case of acute nitrobenzene poisoning
timely management in form of repeated intravenous methylene blue
a vital role to save a life. It is very
exposure form the secondary cycling of nitrobenzene from body stores.
of this uncommon, but treatable and potential serious poisoning
Methemogobinemia can leads to high mortality but effective treatment with methylene blue is
preferential.
Key words
Acute methemoglobinemia, Methylene blue, N
Introduction
Nitrobenzene is also known as nitrobenzol,
mirbane oil or essence of mirbane
introduced into the body, it is metabolized by
reduction to aniline. Nitrobenzene and aniline
are typical aromatic nitro compounds and
aromatic amino compounds that cause
methemoglobinemia.
methemoglobinemia due to acute nitrobenzene
poisoning is uncommon and rare but life
threatening emergency condition. Once
poisoning is suspected on clinical evaluation,
early and effective management of it may
ate presentation of secondary cycling - nitrobenzene poisoning
International Archives of Integrated Medicine, Vol. 1, Issue. 3, November, 2014.
Rights Reserved.
Late presentation of secondary cycling
nitrobenzene poisoning: A rare case report
Virendra Goyal*
142,Taruchaya Nagar, Tonk Road, Jaipur, Rajasthan, India
*Corresponding author’s email: [email protected]
Virendra Goyal. Late presentation of secondary cycling
: A rare case report. IAIM, 2014; 1(3): 39-43.
Available online at www.iaimjournal.com
2014 Accepted on:
case of acute nitrobenzene poisoning in which effective clinical evaluation and
repeated intravenous methylene blue and blood transfusions
very important to take care of patient who presented late after heavy
the secondary cycling of nitrobenzene from body stores. Clinicians should be aware
but treatable and potential serious poisoning
Methemogobinemia can leads to high mortality but effective treatment with methylene blue is
Acute methemoglobinemia, Methylene blue, Nitrobenzene poisoning, Blood transfusion.
Nitrobenzene is also known as nitrobenzol,
mirbane oil or essence of mirbane. When
introduced into the body, it is metabolized by
Nitrobenzene and aniline
are typical aromatic nitro compounds and
aromatic amino compounds that cause
Significant
methemoglobinemia due to acute nitrobenzene
soning is uncommon and rare but life
threatening emergency condition. Once
poisoning is suspected on clinical evaluation,
early and effective management of it may
change the outcome of a patient in positive
manner.
Case report
A 30 years old, irritable, anxious male presented
to emergency department who
other centre on mechanical ventilation with
cyanosis and a greyish
examination, he had labored
26/min, blood pressure was
pulse rate was 74/min, pupils with sluggish
reaction, and SpO2 of 89% only. There was a
history of severe pain in the abdomen, nausea,
ISSN: 2394-0026 (P)
ISSN: 2394-0034 (O)
Page 39
Late presentation of secondary cycling -
nitrobenzene poisoning: A rare case report
cycling - nitrobenzene
Accepted on: 20-10-2014
in which effective clinical evaluation and
lood transfusions played
patient who presented late after heavy
Clinicians should be aware
but treatable and potential serious poisoning of nitrobenzene.
Methemogobinemia can leads to high mortality but effective treatment with methylene blue is
, Blood transfusion.
change the outcome of a patient in positive
anxious male presented
department who referred from
on mechanical ventilation with
greyish-brown hue. On
labored respiration of
was 129/74 mm of Hg,
pupils with sluggish
of 89% only. There was a
history of severe pain in the abdomen, nausea,
Late presentation of secondary cycling
International Archives of Integrated Medicine, Vol.
Copy right © 2014, IAIM, All Rights Reserved.
vomiting, and dizziness, which was treated on
admission at primary centre. At primary
oral methylene blue was given (5 ml,
as to non-availability of intravenous therapy
urgent ultrasonography of abdomen
which ruled out any abdominal catastrophe
and showed a generalized mild to
hepatic inflammation. Blood samples
drawn for arterial blood gas (
which had a chocolate brown
not improve on exposure to 100% oxygen and
showed compensated metabolic acidosis.
of the chest and ECG were within normal limits
while WBC and liver enzymes were markedly
raised. Serum creatinine and blood urea were
within normal range. Hemoglobin at admission
was 9.4 gm%, which dropped down to 6.3
on 9th
day. Similarly serum bilirubin at admission
was 2.0 mg% which was raised to 13.0 mg%. A
clinical diagnosis of s
methemoglobinemia due to
poisoning was made.
100 mg of methylene blue (p
sterile solution) was given intravenously and
repeated after 12 hours. This im
SpO2 to 92% and then after intravenous vitamin
K; vitamin C, 10% dextrose, anxi
and intravenous antibiotic were also given
Urine output was maintained above 100
ml/hour with proper hydration, maintaining a
normal central venous pressure (CVP).
Multiple blood and blood products
frozen plasma (FFP) were transfused. Patient at
admission had severe hypokalemia
which was corrected by intravenous
potassium infusion. Methemoglobin estimation
in blood was done and it was significantly high
(11.1 units as compared to normal values of 0.00
to 2.0). He was extubated at 48 hours and
maintained on a continuous positive airway
pressure (CPAP) mask, with arterial blood gas
(ABG) analysis which showed
ate presentation of secondary cycling - nitrobenzene poisoning
International Archives of Integrated Medicine, Vol. 1, Issue. 3, November, 2014.
Rights Reserved.
vomiting, and dizziness, which was treated on
t primary centre,
(5 ml, 12 hourly),
intravenous therapy. An
abdomen was done
ruled out any abdominal catastrophe
zed mild to moderate
hepatic inflammation. Blood samples were
arterial blood gas (ABG) analysis
had a chocolate brown color, which did
not improve on exposure to 100% oxygen and
compensated metabolic acidosis. X-ray
G were within normal limits
nd liver enzymes were markedly
and blood urea were
within normal range. Hemoglobin at admission
which dropped down to 6.3 gm%
bilirubin at admission
mg% which was raised to 13.0 mg%. A
clinical diagnosis of severe acute
due to nitrobenzene
mg of methylene blue (prepared as 1%
sterile solution) was given intravenously and
. This improved patient’s
ntravenous vitamin
K; vitamin C, 10% dextrose, anxiolytics, oral iron,
were also given.
Urine output was maintained above 100
ml/hour with proper hydration, maintaining a
normal central venous pressure (CVP).
blood products like fresh
transfused. Patient at
hypokalemia (2.5 mEq/L),
which was corrected by intravenous slow
hemoglobin estimation
it was significantly high
to normal values of 0.00
He was extubated at 48 hours and
continuous positive airway
arterial blood gas
a saturation of
93% and a PaO2 of 112. He improved rapidly
after the 10th
day with SpO2
Patient had a single episode of
clonic seizure (GTCS) on 11
epsolinised, followed by oral dilantin tablets
(100 mg TDS). CT head was absolutely nor
but liver enzymes were raised. He was
discharged on the 14th
day on oral iron, folate,
ascorbic acid, and liver enzyme supplements and
breathing exercises.
Discussion
Nitrobenzene is a pale yellow, oily liquid, with
bitter almond odor and it is widely used as an
intermediate in the production of various
solvents, like paint remover. Common
occupational exposure of nitrobenzene is via
inhalation or through absorption of skin [1, 2
1886, first report of nitrobenzene poisoning was
noted [3] and then after various fatality reports
were come into noticed [
poisoning can be accidental or suicidal in
manner [5]. Accidental exposure may possible in
patients who are consuming well water with
extremely high levels of nitri
[6]. Lethal dose of it is varied from 1
different scholar authors [7, 8, 9
literature review of already published articles on
it does not provide any significant conclusive
matter regarding fatalities and
[8]. Nitrobenzene poisoning is usually presented
as chronic poisoning or as occupational hazard
with development of methemoglobinemia [10].
The clinical features of ingestion of such poison
are due to the rapid development of
methemoglobinemia [7, 11], which is a condition
of altered hemoglobin formation in which the
iron presented within the hemoglobin is
oxidized into ferric (Fe3+
) state from the ferrous
(Fe2+
) state, resulting in the inability to transport
oxygen effectively [12, 13, 14
brownish discoloration of the blood and
functional anemia [6]. After formation of
ISSN: 2394-0026 (P)
ISSN: 2394-0034 (O)
Page 40
of 112. He improved rapidly
2 of 90% on room air.
Patient had a single episode of generalized tonic
on 11th
day and was
followed by oral dilantin tablets
CT head was absolutely normal
liver enzymes were raised. He was
day on oral iron, folate,
ascorbic acid, and liver enzyme supplements and
Nitrobenzene is a pale yellow, oily liquid, with
and it is widely used as an
intermediate in the production of various
solvents, like paint remover. Common
occupational exposure of nitrobenzene is via
gh absorption of skin [1, 2]. In
1886, first report of nitrobenzene poisoning was
] and then after various fatality reports
into noticed [3, 4]. Nitrobenzene
poisoning can be accidental or suicidal in
]. Accidental exposure may possible in
patients who are consuming well water with
extremely high levels of nitrites and nitrates in it
]. Lethal dose of it is varied from 1-10 g, as per
7, 8, 9]. A systematic
literature review of already published articles on
it does not provide any significant conclusive
matter regarding fatalities and dose of ingestion
]. Nitrobenzene poisoning is usually presented
as chronic poisoning or as occupational hazard
with development of methemoglobinemia [10].
The clinical features of ingestion of such poison
are due to the rapid development of
], which is a condition
of altered hemoglobin formation in which the
iron presented within the hemoglobin is
) state from the ferrous
) state, resulting in the inability to transport
[12, 13, 14] and causes
brownish discoloration of the blood and
]. After formation of
Late presentation of secondary cycling
International Archives of Integrated Medicine, Vol.
Copy right © 2014, IAIM, All Rights Reserved.
methemoglobin, it can be reduced enzymatically
either via an adenine dinucleotide (NADH)
dependent reaction, which is catalysed by
cytochrome b5 reductase, or an
pathway utilizing the nicotine adenine
dinucleotide phosphate [15]. Certain drugs and
chemicals can accelerate production of
methemoglobin like antimalarial drugs such as
chloroquine and primaquine; nitrites or nitrates,
flutamide, inhaled nitric oxide, metoclopramide,
local anesthetic agents like benzocaine;
acetanilide, nitroprusside, sulfonamides,
phenacetin, phenazopyridine hydrochloride,
phenytoin, chlorates, probenecid etc. [1
Normal physiological level of Methemoglobin i
less than 1% of total hemoglobin [17
10-15% of methemoglobin, person is usually
asymptomatic with mild cyanotic changes.
When methemoglobin level is 20
headache, dyspnea, chest pain, tachypnea, and
tachycardia develop [18]. At 40
methemoglobin, person feels confusion,
lethargy, and metabolic acidosis which later on
leading to coma, seizures, bradycardia,
ventricular dysrythmia, and hypertension
Methemoglobin level around 70% is considered
as fatal [20]. More severe symptoms are noted
in patients with anemia or G6PD deficiency [
7]. In certain cases, leukocytosis has been
reported along with relative lymphopenia [
Altered liver function tests, hepato
splenomegaly, and Heinz body haemolytic
anaemia are other significant features [
22]. Nitrobenzene is metabolized in the body
and converted into p-nitrophenol and
aminophenol and later on excreted in urine (up
to 65%), and in stools (up to 15%) after five days
of ingestion. Liver, stomach, blood, and brain
may act as storage house and release it
gradually [21].
History of chemical ingestion, characteristic
bitter almond smell, persisting cyanosis on
ate presentation of secondary cycling - nitrobenzene poisoning
International Archives of Integrated Medicine, Vol. 1, Issue. 3, November, 2014.
Rights Reserved.
methemoglobin, it can be reduced enzymatically
either via an adenine dinucleotide (NADH)-
dependent reaction, which is catalysed by
cytochrome b5 reductase, or an alternative
pathway utilizing the nicotine adenine
Certain drugs and
chemicals can accelerate production of
methemoglobin like antimalarial drugs such as
chloroquine and primaquine; nitrites or nitrates,
, inhaled nitric oxide, metoclopramide,
local anesthetic agents like benzocaine;
acetanilide, nitroprusside, sulfonamides,
phenacetin, phenazopyridine hydrochloride,
phenytoin, chlorates, probenecid etc. [16].
Normal physiological level of Methemoglobin is
than 1% of total hemoglobin [17]. At level of
15% of methemoglobin, person is usually
asymptomatic with mild cyanotic changes.
When methemoglobin level is 20-40%,
headache, dyspnea, chest pain, tachypnea, and
]. At 40 – 50% level of
methemoglobin, person feels confusion,
lethargy, and metabolic acidosis which later on
leading to coma, seizures, bradycardia,
ventricular dysrythmia, and hypertension [19].
Methemoglobin level around 70% is considered
symptoms are noted
in patients with anemia or G6PD deficiency [4,
]. In certain cases, leukocytosis has been
reported along with relative lymphopenia [8].
Altered liver function tests, hepato-
splenomegaly, and Heinz body haemolytic
ficant features [4, 21,
]. Nitrobenzene is metabolized in the body
nitrophenol and
aminophenol and later on excreted in urine (up
to 65%), and in stools (up to 15%) after five days
of ingestion. Liver, stomach, blood, and brain
ct as storage house and release it
History of chemical ingestion, characteristic
bitter almond smell, persisting cyanosis on
oxygen therapy without severe cardiopulmonary
disease, low arterial oxygen saturation, with
normal ABG (calculated) oxygen saturation are
very important for diagnosis.
detection can be done bedside by placing few
drops of blood on white filter paper and
observing for color change in which
deoxyhemoglobin brighten and methemoglobin
holds color [23]. Dark brown blood that fails to
turn bright red on shaking, which suggests
methaemoglobinaemia and this is supported by
the chocolate red color of dried blood. Presence
of nitrobenzene compounds may be confirmed
spectrophotometrically and estimated by the
butanone test of Schrenk [1], methemoglobin
levels in the blood, and urinary presence of p
nitrophenol and p-aminophenol [
Plan of management is based upon the
principles of decontamination along with
symptomatic and supportive treatment.
Methylene blue is the drug of choice (antidote)
for the treatment of acquired (toxic)
methaemoglobinaemia [25]. It is an exogenous
cofactor, which greatly accelerates the NADPH
dependant methemoglobin reductase system
and is indicated if the methemoglobin levels,
which are more than 30% [7
intravenously at 1 – 2 mg/kg (up to 50 mg dose
in adults,) as a 1% solution over five minutes;
with a repeat in one hour, if necessary.
Methylene blue is act as an oxidant at levels of
more than 7 mg/kg, and the
methaemoglobinaemia in susceptible patients
[26]. It is contraindicated in patients with G6PD
deficiency, because it can lead to severe
haemolysis. Ascorbic acid is an antioxidant that
may also be administered in patients with
methemoglobin levels of more than 30% [
recent studies, N-acetylcysteine has been shown
to reduce methemoglobin, but it is not yet an
approved treatment for methaemoglobinaemia
[27]. Exchange transfusion is indicated in severe
cases [7, 27]. Hyperbaric oxygen
ISSN: 2394-0026 (P)
ISSN: 2394-0034 (O)
Page 41
oxygen therapy without severe cardiopulmonary
disease, low arterial oxygen saturation, with
) oxygen saturation are
very important for diagnosis. Methemoglobin
detection can be done bedside by placing few
drops of blood on white filter paper and
observing for color change in which
deoxyhemoglobin brighten and methemoglobin
brown blood that fails to
turn bright red on shaking, which suggests
methaemoglobinaemia and this is supported by
the chocolate red color of dried blood. Presence
of nitrobenzene compounds may be confirmed
spectrophotometrically and estimated by the
ne test of Schrenk [1], methemoglobin
levels in the blood, and urinary presence of p-
aminophenol [3, 21, 24].
Plan of management is based upon the
principles of decontamination along with
symptomatic and supportive treatment.
lue is the drug of choice (antidote)
for the treatment of acquired (toxic)
]. It is an exogenous
cofactor, which greatly accelerates the NADPH-
dependant methemoglobin reductase system
and is indicated if the methemoglobin levels,
7]. It is administered
2 mg/kg (up to 50 mg dose
in adults,) as a 1% solution over five minutes;
with a repeat in one hour, if necessary.
Methylene blue is act as an oxidant at levels of
more than 7 mg/kg, and therefore, may cause
methaemoglobinaemia in susceptible patients
]. It is contraindicated in patients with G6PD
deficiency, because it can lead to severe
haemolysis. Ascorbic acid is an antioxidant that
may also be administered in patients with
in levels of more than 30% [27]. In
acetylcysteine has been shown
to reduce methemoglobin, but it is not yet an
approved treatment for methaemoglobinaemia
]. Exchange transfusion is indicated in severe
]. Hyperbaric oxygen is reserved only
Late presentation of secondary cycling
International Archives of Integrated Medicine, Vol.
Copy right © 2014, IAIM, All Rights Reserved.
for those patients who have a methemoglobin
level > 50% or those who do not respond to
standard treatment. Exchange transfusion is
more widely and rapidly available compared to
hyperbaric oxygen. Exchange transfusion
involves replacement of the patient's red cells
with donor cells and has been used in the
treatment of various hemoglobinopathies
In this case, we repeated low dose methylene
blue and blood transfusions helped in tiding
over the fluctuating symptoms due to the
release of nitrobenzene from the body stores,
without exceeding the maximum dose. Fresh
blood transfusion improved the oxygen carrying
capacity and haemoglobin content, improving
the patient symptomatically. Oral charcoal and
purgation up to five days helped to elimi
body stores of nitrobenzene and prevented
secondary deterioration in the patient
care of nutrition, adequate urine output, and
hepatoprotection prevented kidney and liver
failure, which have been cited as late effects [
21]. Regular use of charcoal and purgation by
peglag during hospital stay may be of some help
according to some centers. Forced diuresis can
lead to a rapid fall in methemoglobin levels and
improved discoloration [8]. Ascorbic acid
supplements are useful for follow
management of methaemoglobinaemia [
Conclusion
Clinicians should be aware of this uncommon,
but treatable and potential serious poisoning
nitrobenzene with secondary cycling from the
body tissues. Methemogobinemia
high mortality but effective treatment with
methylene blue is preferential.
Acknowledgement
The author is highly thankful to Jeevanrekha
CCTH, Jaipur team for their kind coop
and wholehearted support in.
ate presentation of secondary cycling - nitrobenzene poisoning
International Archives of Integrated Medicine, Vol. 1, Issue. 3, November, 2014.
Rights Reserved.
for those patients who have a methemoglobin
level > 50% or those who do not respond to
Exchange transfusion is
more widely and rapidly available compared to
hyperbaric oxygen. Exchange transfusion
f the patient's red cells
with donor cells and has been used in the
treatment of various hemoglobinopathies [15].
In this case, we repeated low dose methylene
blue and blood transfusions helped in tiding
over the fluctuating symptoms due to the
nitrobenzene from the body stores,
without exceeding the maximum dose. Fresh
blood transfusion improved the oxygen carrying
capacity and haemoglobin content, improving
Oral charcoal and
purgation up to five days helped to eliminate the
body stores of nitrobenzene and prevented
secondary deterioration in the patient .Taking
care of nutrition, adequate urine output, and
hepatoprotection prevented kidney and liver
failure, which have been cited as late effects [3,
of charcoal and purgation by
peglag during hospital stay may be of some help
according to some centers. Forced diuresis can
lead to a rapid fall in methemoglobin levels and
]. Ascorbic acid
supplements are useful for follow-up
gement of methaemoglobinaemia [28].
Clinicians should be aware of this uncommon,
but treatable and potential serious poisoning of
with secondary cycling from the
Methemogobinemia can leads to
high mortality but effective treatment with
The author is highly thankful to Jeevanrekha
Jaipur team for their kind cooperation
References
1. Min JW, Park SY, Lee GR, J
JY, Cho YJ, Nam HW.
methemoglobinemia caused by
nitrobenzene ingestion.
2013; 84(3): 442–445.
2. Martinez MA, Ballesteros S, Almarza E,
Sanchez de la Torre C, Bua S
nitrobenzene poisoning with severe
associated methe
Identification in whole blood by GF
and GC-MS. J Anal Toxicol
221–5.
3. Gupta G, Poddar B, Salaria M, Parmar V.
Acute nitrobenzene poisoning.
Pediatr., 2000; 37: 1
4. Dutta R, Dube SK, Mishra LD, Singh AP.
Acute methemglobinemia.
Emerg Intensive Care Med.,
1092–4051.
5. R. Ewert, E Buttgereit, M. PrCigel,
Reinke. Intravenous injection of India ink
with suicidal intent. Int.J. Med.
LegalMed., 1998; 111: 91
6. Michelle, Kumar M.
Methemoglobinemia overview. e
medicine from web med. Available from:
http://www.emedicine.medscape.com
article/956528-overview
2010.
7. Chongtham DS, Phurailatpam
MM, Singh TR. Methemglobinemia in
nitrobenzene poisoning.
Med., 1997; 43: 73–
8. International Program on Chemical
safety (IPCS)
Nitrobenzene. Environmental health
criteria 230. Geneva: WHO. Available
from:
http://www.inchem.org
/ehc/ ehc230.htm#8.1.1;#7.8
in 2003.
9. Harris JC, Rumack BH, Paterson RG, Mc
Guire BM. Methaemoglobinemia
ISSN: 2394-0026 (P)
ISSN: 2394-0034 (O)
Page 42
Min JW, Park SY, Lee GR, Jeon YD, Jung
JY, Cho YJ, Nam HW. Case of acute
methemoglobinemia caused by
nitrobenzene ingestion. Korean J Med,
445.
Martinez MA, Ballesteros S, Almarza E,
Sanchez de la Torre C, Bua S. Acute
nitrobenzene poisoning with severe
associated methemoglobinmeia:
dentification in whole blood by GF-FID
J Anal Toxicol, 2003; 27(4):
Gupta G, Poddar B, Salaria M, Parmar V.
Acute nitrobenzene poisoning. Indian
Pediatr., 2000; 37: 1147–8.
Dutta R, Dube SK, Mishra LD, Singh AP.
Acute methemglobinemia. Internet J
Emerg Intensive Care Med., 2008; 11:
, E Buttgereit, M. PrCigel, R
Reinke. Intravenous injection of India ink
with suicidal intent. Int.J. Med.
1998; 111: 91-92.
Michelle, Kumar M.
Methemoglobinemia overview. e
medicine from web med. Available from:
www.emedicine.medscape.com/
overview. Accessed in
Chongtham DS, Phurailatpam, Singh
MM, Singh TR. Methemglobinemia in
nitrobenzene poisoning. J Postgrad
–4.
International Program on Chemical
– 2003 (8.11)
Nitrobenzene. Environmental health
Geneva: WHO. Available
www.inchem.org/documents/ehc
/ ehc230.htm#8.1.1;#7.8. Accessed
Harris JC, Rumack BH, Paterson RG, Mc
Guire BM. Methaemoglobinemia
Late presentation of secondary cycling
International Archives of Integrated Medicine, Vol.
Copy right © 2014, IAIM, All Rights Reserved.
resulting from absorption of nitrates.
JAMA, 1979; 242: 2869-2871.
10. Aruna Dewan, Ashwin Patel,
Saiyed. Acute Methemoglobinemia
Common Occuptional Hazard in an
Industrial City in Western India. J Occup
Health, 2001; 43: 168-171.
11. Schimelman MA, Soler JM, Muller HA.
Methaemoglobinem: Nitrobenzene
ingestion. J Am Coll Emerg Phys
406-408.
12. Bradberry SM, Aw TC, Williams NR, Vale
JA. Occupational methemoglobinaemia.
Occup Environ Med, 2001;
616.
13. Park SS, Nam EM, Kim IH, Kim JS, Lim YJ,
Ahn SJ. A case of methemoglobinemia
caused by hair dyeing with henna.
Korean J Med, 2007; 72(2):
14. Shin JH, Lee JK, Park SS, Na SJ, Park JS.
Indoxacarb pesticide poisoning with
methemoglobinemia. J Korean Soc Clin
Toxicol, 2006; 4(2): 158.
15. Michael A. Pritchett, Nathalie Celestin,
Nicole Tilluckdharry, Katherine Hendra,
Peter Lee. Successful Treatme
refractory methemoglobinemia with red
blood cell exchange transfusion
Meeting Abstracts, 2006
16. Ferraro-Borgida MJ, Mulhern SA, DeMeo
MO, Bayer MJ. Methemoglobinemia
from perineal appliction of an anesthetic
cream. Ann Emerg Med
8.
17. Mansouri A. Review:
Methaemoglobinemia. Am J Med Sci
1985; 29: 200-209.
18. Walley T, Flangan M. Nitrite
methaemoglobinemia. Postgrad Med J
1987; 63: 643-644.
19. Piotrowski. Further investigations on the
evaluation of exposure to
Br. J. Ind. Med., 1967; 24:
ate presentation of secondary cycling - nitrobenzene poisoning
International Archives of Integrated Medicine, Vol. 1, Issue. 3, November, 2014.
Rights Reserved.
resulting from absorption of nitrates.
2871.
Aruna Dewan, Ashwin Patel, Habibullah
ute Methemoglobinemia - A
Common Occuptional Hazard in an
Industrial City in Western India. J Occup
171.
Schimelman MA, Soler JM, Muller HA.
Methaemoglobinem: Nitrobenzene
ingestion. J Am Coll Emerg Phys, 1978; 7:
SM, Aw TC, Williams NR, Vale
Occupational methemoglobinaemia.
2001; 58(9): 611–
Kim IH, Kim JS, Lim YJ,
A case of methemoglobinemia
caused by hair dyeing with henna.
(2): 314–317.
Lee JK, Park SS, Na SJ, Park JS.
Indoxacarb pesticide poisoning with
J Korean Soc Clin
158.–160.
Michael A. Pritchett, Nathalie Celestin,
Nicole Tilluckdharry, Katherine Hendra,
Successful Treatment of
refractory methemoglobinemia with red
blood cell exchange transfusion. Chest
2006; 130(4): 294.
Borgida MJ, Mulhern SA, DeMeo
MO, Bayer MJ. Methemoglobinemia
from perineal appliction of an anesthetic
cream. Ann Emerg Med, 1996; 27: 785-
Mansouri A. Review:
Methaemoglobinemia. Am J Med Sci,
Walley T, Flangan M. Nitrite-induced
Postgrad Med J,
Piotrowski. Further investigations on the
evaluation of exposure to nitrobenzene.
24: 60-67.
20. Eisen Kraft JB. Pulse oximeter
desaturation due to
methaemoglobinemia
1988; 68: 279-282.
21. Wakefield JC. Nitrobenzene toxicological
overview file format. Available
form: http://www.hpa.org.uk/web/HPA
webFile/HPAweb_C/1222068850334
ge 1-10. Accessed in 2008.
22. David C Lee. Methemoglobinemia
eMedicine from web
2012.
23. Mary Denshaw-Burke, John Schofstall
Methhemoglobinemia
web med. Accessed in 2012.
24. Verive M, Kumar M.
Methemglobinemia: Differential
diagnoses and workup, e medicine from
web med. Available
from: http://www.emedicine.medscape.
com/article/956528-
in 2010.
25. Curry S. Methaemoglobinemia. Ann
Emerg Med, 1982; 11:
26. Whitwan JG, Taylor AR, White JM.
Potential hazard of methylene blue.
Anaesthesia, 1979; 34:
27. Verive M, Kumar M.
Methemglobinemia: Treatment and
Medication, e medicine from web med.
Available
from: http://www.emedicine.medscape.
com/article/956528-
treatment. Accessed in 2010
28. Kaushik P, Zuckerman SJ, Campo NJ,
Banda VR, Hayes SD, Kaushik R.
Celecoxib Induced
Methemoglobinemia.
Pharmacother., 2004; 38: 1635
Source of support: Nil
Conflict of interest: None declared.
ISSN: 2394-0026 (P)
ISSN: 2394-0034 (O)
Page 43
Eisen Kraft JB. Pulse oximeter
desaturation due to
methaemoglobinemia. Anaesthesiology,
Wakefield JC. Nitrobenzene toxicological
overview file format. Available
http://www.hpa.org.uk/web/HPA
webFile/HPAweb_C/1222068850334 pa
10. Accessed in 2008.
Methemoglobinemia.
eb med. Accessed in
Burke, John Schofstall.
ethhemoglobinemia. eMedicine from
Accessed in 2012.
Verive M, Kumar M.
Methemglobinemia: Differential
diagnoses and workup, e medicine from
web med. Available
http://www.emedicine.medscape.
-diagnosis. Accessed
Curry S. Methaemoglobinemia. Ann
1982; 11: 214-221.
Whitwan JG, Taylor AR, White JM.
Potential hazard of methylene blue.
1979; 34: 181-182.
Verive M, Kumar M.
Methemglobinemia: Treatment and
Medication, e medicine from web med.
http://www.emedicine.medscape.
-
Accessed in 2010.
Kaushik P, Zuckerman SJ, Campo NJ,
Banda VR, Hayes SD, Kaushik R.
Celecoxib Induced
Methemoglobinemia. Ann
2004; 38: 1635–8.
None declared.